Precancerous Cervical Lesions and Associated Factors Among Women Attending Cervical Screening at Adama Hospital Medical College, Central Ethiopia

References

• Ethiopia FMoH. National Cancer Control Plan 2016–2020.. Ethiopia,Addis Ababa; 2015. Available from: www.iccp-portal.org. Accessed 220, 2021.
   Google Scholar
• World Health Organization. 2014. ComprehensiveCervical Cancer Contro a Guide to Essential Practice. 2nd ed. Geneva. https://www.ncbi.nlm.nih.gov/pubmed/25642554. Accessed 220, 2021.
   Google Scholar
• Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 17 June 2019. Available from: https://www.hpvcentre.net/statistics/reports/XWX.pdfPDFfile. Accessed 220, 2021.
   Google Scholar
• Pathfinder international. Single-Visit Approach to Cervical Cancer Prevention; Clinical Standards of Practice and Counseling Guidelines. May 2013. Available from: https://www.who.int/pmnch/media/news/2012/201210. Accessed 220, 2021.
   Google Scholar
• Shiferaw N, Salvador-Davila G, Kassahun K, et al. The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: successes and lessons learned. Glob Health Sci Pract. 2016;4(1):87–98. doi:10.9745/GHSP-D-15-0032527016546
   PubMedGoogle Scholar
• World Health Organization. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva; 2013. Available from: www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/index.html. Accessed 220, 2021.
   Google Scholar
• Federal Democratic Republic of Ethiopia Ministry of Health. Guideline for Cervical Cancer Prevention and Control in Ethiopia January 2015.
   Google Scholar
• World Health Organization, Regional Office for South-East Asia. Strategic Framework for the Comprehensive Control of Cancer Cervix in South-East Asia Region. Geneva: World Health Organization, Regional Office for South-East Asia; 2015. Available from: https://apps.who.int/iris/handle/10665/152098. Accessed 220, 2021.
   Google Scholar
• Netsanet A A. Cervical Cancer: ethiopia’s Outlook. J Gynecol Women’s Health. 2017;5(2):555660. doi:10.19080/JGWH.MS.ID.555660.
   Google Scholar
• Pathfider E VIA screening and cryotherapy of cervical cancer for HIV positive women under the project name of “Addis Tesfa“ Cervical Cancer prevention (CCP) project. 2009-2014
   Google Scholar
• Federal Democratic Republic of Ethiopia Ministry of Health. Health Sector Development Programme IV 2010/11-2014/15. Addis Ababa; 2014. www.healthynewbornnetwork.orghnn-contentuploads.
   Google Scholar
• Misgina KH, Belay HS, Abraha TH. Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. J Public Health Epidemiol. 2017;9(3):46–50. doi:10.5897/JPHE2016.0891
   Google Scholar
• Teame H, Addissie A, Ayele W, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS One. 2018;13(1):e0191506. doi:10.1371/journal.pone.019150629352278
   PubMed Web of Science ®Google Scholar
• Hailemariam T, Yohannes B, Aschenaki H, et al. Prevalence of cervical cancer and associated risk factors among women attending cervical cancer screening and diagnosis center at Yirgalem General Hospital, Southern Ethiopia. J Cancer Sci Ther. 2017;9(11):730–735. doi:10.4172/1948-5956.1000500
   Google Scholar
• Deksissa ZM, Tesfamichael FA, Ferede HA. Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. BMC Res Notes. 2015;8:618. doi:10.1186/s13104-015-1594-x26515769
   PubMedGoogle Scholar
• Damascène MJ, Nsanzimana S, Aimee MM, Pace LE, Ntaganira J, Riedel RDJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;12:1. doi:10.11604/pamj.2015.22.26.7116
   Google Scholar
• Maree JE, Wright SC. Sexual and menstrual practices: risks for cervix cancer. Health SA Gesondheid. 2007;12(3). doi:10.4102/hsag.v12i3.265
   Google Scholar
• Burd EM. Human Papillomavirus And Cervical Cancer. Clin Microbiol Rev. 2003;16(1):1–17.12525422
   PubMed Web of Science ®Google Scholar
• Jamie Eske, Carolyn Kay. Medically reviewed newsletter;2019 Available from: https://www.medicalnewstoday.com/articles/326543. Accessed 220, 2021.
   Google Scholar
• Skapinyecz J, Smid I, Horváth A, Jeney C, Kardos L, Kovács P. Pelvic inflammatory disease is a risk factor for cervical cancer. Eur J Gynaecol Oncol. 2003;24(5):401–404.14584656
   PubMed Web of Science ®Google Scholar
• America Cancer Society. Cervical Cancer Causes, Risk Factors, and Prevention. cancer.org | 1.800.227.2345 https://www.cancer.org/cancer/cervical-cancer/causes-risks-prevention/risk-factors.html. Accessed 220, 2021.
   Google Scholar
• Kassa RT. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia: a case control study. BMC Res Notes. 2018;11:145. doi:10.1186/s13104-018-3244-629463299
   PubMedGoogle Scholar
• Jolly PE, Mthethwa-Hleta S, Padilla LA, et al. screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. BMC Public Health. 2017;17:218. doi:10.1186/s12889-017-4120-328222714
   PubMed Web of Science ®Google Scholar
• Poli UR, Bidinger PD, Gowrishankar S. Visual Inspection with Acetic Acid (VIA) Screening program: 7 years experience in early detection of cervical cancer and pre-cancers in rural South India. Indian J Commun Med. 2015;40(3):203–207. doi:10.4103/0970-0218.158873
   PubMedGoogle Scholar
• Measures Evaluation. Percent of VIA (visual inspection with acetic acid) screenings that test positive. Available from: www.measureevaluation.orgprhcervical-cancer. Accessed 220, 2021.
   Google Scholar